<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bayu Aditya Nugraha</style></author><author><style face="normal" font="default" size="100%">Brahmana Askandar Tjokroprawiro</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Clinicopathological Analysis of Mucinous Ovarian Tumors at a Single Center in Indonesia, 2019-2023</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Clinicopathological characteristics</style></keyword><keyword><style  face="normal" font="default" size="100%">Indonesia</style></keyword><keyword><style  face="normal" font="default" size="100%">Mucinous ovarian tumors</style></keyword><keyword><style  face="normal" font="default" size="100%">Single center</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">1138-1142</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Mucinous ovarian tumors are a rare subtype of epithelial ovarian tumors, accounting for approximately 3% of all cases. These tumors exhibit unique clinical and pathological characteristics, with a particularly poor prognosis in advanced stages due to low responsiveness to platinum-based chemotherapy. &lt;strong&gt;Objective:&lt;/strong&gt; This study aims to analyze the relationships between clinicopathological characteristics in patients with mucinous ovarian tumors treated at a single center in Indonesia between 2019 and 2023. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; A correlational study from March to June 2024 analyzed patients with confirmed mucinous ovarian tumors in Indonesia, focusing on age, histopathological grade, FIGO stage, CA-125 levels, tumor size, and metastasis presence. &lt;strong&gt;Results&lt;/strong&gt;: A study of 123 mucinous ovarian tumor patients found that 57.7% were over 40. Histopathological analysis revealed 21.1% were benign, 26% borderline, and 52.8% malignant. Patients over 40 had more malignant tumors, advanced-stage disease, and omental metastasis. A significant correlation was found between malignant histopathology and advanced FIGO stage, as well as between advanced FIGO stage and both lymph node and omental metastasis. Tumor size was associated with elevated CA-125 levels and bilateral tumors. &lt;strong&gt;Conclusion: &lt;/strong&gt;Mucinous ovarian tumors in patients over 40 years old are more likely to be malignant, present at an advanced stage, and involve omental metastasis. Malignant histopathological results are associated with advanced FIGO stages, which in turn are linked to lymph node and omental metastasis. Tumors larger than 10 cm tend to have elevated CA-125 levels.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1138</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Bayu Aditya Nugraha&lt;sup&gt;1&lt;/sup&gt;, Brahmana Askandar Tjokroprawiro&lt;sup&gt;2*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Resident of Obstetrics and Gynecology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Academic Hospital, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Academic Hospital, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Meity Ardiana</style></author><author><style face="normal" font="default" size="100%">Nastiti Imana Intansari</style></author><author><style face="normal" font="default" size="100%">Asiyah Nurul Fadila</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The Consequences of Hypertension and Obesity on Coronary Heart Disease</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style  face="normal" font="default" size="100%">Cardiovascular Disease</style></keyword><keyword><style  face="normal" font="default" size="100%">Coronary Heart Disease</style></keyword><keyword><style  face="normal" font="default" size="100%">High blood pressure</style></keyword><keyword><style  face="normal" font="default" size="100%">Indonesia</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">1331-1335</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Coronary heart disease (CHD) is the leading cause of death worldwide. At present, more than 20 million adults suffer from CHD, and the number keeps increasing. Hypertension and obesity, known risk factors of CHD, are also inclining in prevalence. Given the diversities of world population, studies on correlation of hypertension and obesity in the incidence of CHD still have a lot to unveil. &lt;strong&gt;Aim:&lt;/strong&gt; to analyze the association between hypertension and obesity to CHD as both independent and dependent risk factors. &lt;strong&gt;Method: &lt;/strong&gt;A cross-sectional descriptive study on 100 hypertensive subjects was conducted from March to November 2022. Subjects were selected by simple random sampling technique. The data were collected by anamnesis, physical examination, laboratory examination, electrocardiography, and by checking on medical records if needed. Statistical analysis was conducted using SPSS. &lt;strong&gt;Result:&lt;/strong&gt; The mean age of the study samples was 58.64 years old. The mean value of BMI was 25.77 ± 5.21 SD, and 53.6% of the participants was obese. 33% of the subjects were diagnosed with CHD. There was no correlation between obesity and CHD (OR = 0.582, 95% CI = 0.245-1.382); between hypertension on therapy or without therapy and CHD (OR= 0.729, 95% CI= 0.15-15.09). There was also no correlation between length of hypertension and CHD (R= 0.117; p = 0.27). &lt;strong&gt;Conclusion: &lt;/strong&gt;This study shows no significant correlations between hypertension, obesity, and CHD. Whether socioeconomic and demographic profile play a part in the association of hypertension and obesity with CHD, specifically for Indonesian ethnicities, should be studied further.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1331</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Meity Ardiana¹'², Nastiti Imana Intansari¹'²*, Asiyah Nurul Fadila¹'²&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Cardiology and Vascular Medicine, Dr. Soetomo General Academic Hospital, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Faculty of Medicine, Airlangga University, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Chairul A. Nidom</style></author><author><style face="normal" font="default" size="100%">Arif N. M. Ansori</style></author><author><style face="normal" font="default" size="100%">Astria N. Nidom</style></author><author><style face="normal" font="default" size="100%">Setyarina Indrasari</style></author><author><style face="normal" font="default" size="100%">Reviany V. Nidom</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Curcumin from Curcuma longa L. as Dual Inhibitors Against Indonesian SARS-CoV-2 Isolates: A Molecular Docking Study</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">COVID-19</style></keyword><keyword><style  face="normal" font="default" size="100%">Curcumin</style></keyword><keyword><style  face="normal" font="default" size="100%">Indonesia</style></keyword><keyword><style  face="normal" font="default" size="100%">Molecular docking</style></keyword><keyword><style  face="normal" font="default" size="100%">SARS-CoV-2</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">March 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">228-232</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;COVID-19 has become a global pandemic since 2020. The search for promising drugs based on the abundant herbal ingredients in Indonesia is one of the breakthroughs. Curcumin is a chemical compound with various potentials such as antioxidant, anti-inflammatory and antiviral. We conducted a molecular docking analysis to determine the potential of curcumin against SARS-CoV-2 non-structural and structural proteins, such as the main protease and spike protein. This study used the compound of curcumin (PubChem CID: 969516) from &lt;em&gt;Curcuma longa&lt;/em&gt; L. or turmeric and two Indonesian SARS-CoV-2 isolates that have been deposited in the GISAID database (hCoV-19/Indonesia/JI-PNF-217315/2021 - EPI_ ISL_12777089 or lineage B.1.617.2 and hCoV-19/Indonesia/JI-PNF-211373/2021 - EPI_ISL_6425649 or lineage B.1.470). In addition, we used molnupiravir (PubChem CID: 145996610) as a drug control. We performed molecular docking analysis with PyRx software 0.9.9 (academic license) and visualization of molecular docking results with PyMOL software 2.5.4 (academic license). The results of this study found that curcumin had good potential against main protease and spike protein compared to the drug (control). In summary, we suggested that curcumin is a potential drug candidate against SARS-CoV-2. However, there is a need for future wet laboratory-based pre-clinical research such as &lt;em&gt;in vitro&lt;/em&gt; and &lt;em&gt;in vivo.&lt;/em&gt;&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">228</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Chairul A. Nidom&lt;sup&gt;1,2*&lt;/sup&gt;, Arif N. M. Ansori&lt;sup&gt;1&lt;/sup&gt;, Astria N. Nidom&lt;sup&gt;1,3&lt;/sup&gt;, Setyarina Indrasari1, Reviany V. Nidom&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Professor Nidom Foundation, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, INDONESIA. 3Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rut Novalia Rahmawati Sianipar</style></author><author><style face="normal" font="default" size="100%">Komar Sutriah</style></author><author><style face="normal" font="default" size="100%">Dyah Iswantini</style></author><author><style face="normal" font="default" size="100%">Suminar Setiati Achmadi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Inhibitory Capacity of Xanthine Oxidase in Antigout Therapy by Indonesian Medicinal Plants</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Competitive inhibition kinetics</style></keyword><keyword><style  face="normal" font="default" size="100%">Flavonoid</style></keyword><keyword><style  face="normal" font="default" size="100%">Gout</style></keyword><keyword><style  face="normal" font="default" size="100%">Indonesia</style></keyword><keyword><style  face="normal" font="default" size="100%">Xanthine Oxidase</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">470-479</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;The traditional medicine has been used in Indonesia since the days of the Ancient Mataram Kingdom (about 12 centuries ago). Indonesia is rich in medicinal plants. For this reason, it is necessary to inform the broader community regarding medicinal plants in Indonesia that have the potential as antigout. The prevalence of gout in Indonesia is in the range of 1.6−13.6 per 100,000 people and will increase with age. There are 25 species of Indonesian plants that have more than 50% xanthine oxidase (XO) enzyme inhibitory activity. XO is responsible for catalyzing hypoxanthine to xanthine then producing uric acid, accompanied by the formation of reactive oxygen species (ROS) during catalysis. The magnitude of the inhibitory power to XO ranged from 50.00±1.16% to 97.53%. The lowest inhibitory power of 50.00±1.16% was in &lt;em&gt;Phaleria macrocarpa,&lt;/em&gt; while Orthosiphon aristatus had the highest inhibitory power of 97.53%. The major compounds that inhibit xanthine oxidase are flavonoids. The structural similarity of flavonoids in rings A and C with xanthine as a substrate causes hydrophobic interactions, hydrogen bonds, and van der Waals forces between flavonoids and XO. It means that flavonoids bind to the XO active site, thereby preventing the formation of uric acid. The type of inhibitory kinetics that occurs between flavonoids and XO is competitive inhibition. Five plants with competitive inhibition kinetics against XO are&lt;em&gt; Sida rhombifolia, Syzygium polyanthum, Cyperus rotundus, Ruellia tuberosa &lt;/em&gt;and &lt;em&gt;Phaleria macrocarpa.&lt;/em&gt;&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">470</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Rut Novalia Rahmawati Sianipar&lt;sup&gt;1&lt;/sup&gt;, Komar Sutriah&lt;sup&gt;1,*&lt;/sup&gt;, Dyah Iswantini&lt;sup&gt;1,2,*&lt;/sup&gt;, Suminar Setiati Achmadi&lt;/strong&gt;&lt;sup&gt;&lt;strong&gt;1,2&lt;/strong&gt; &lt;/sup&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Chemistry, Faculty of Mathematics and Natural Sciences, IPB University, Bogor 16680, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Tropical Biopharmaca Research Center, IPB University, Bogor 16128, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Feda Makkiyah</style></author><author><style face="normal" font="default" size="100%">Eldiza Puji Rahmi</style></author><author><style face="normal" font="default" size="100%">Rika Revina</style></author><author><style face="normal" font="default" size="100%">Tiwuk Susantiningsih</style></author><author><style face="normal" font="default" size="100%">Yuni Setyaningsih</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Graptophyllum pictum (L.) Griff. (Syn: Justicia picta Linn.) and its Effectiveness: A Well-Known Indonesian Plant</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Activities</style></keyword><keyword><style  face="normal" font="default" size="100%">G pictum</style></keyword><keyword><style  face="normal" font="default" size="100%">Indonesia</style></keyword><keyword><style  face="normal" font="default" size="100%">Pharmacological</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">May 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">835-838</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;em&gt;Graptophyllum pictum &lt;/em&gt;(L.) Griff., a shrubby stove plant, has been used traditionally to treat various diseases. This review summarizes the up-to-date data about its phytochemistry and pharmacological properties and provides a perspective and direction for future research. The phytochemical analysis of &lt;em&gt;G. pictum&lt;/em&gt; revealed the presence of flavonoids, steroids, glycoside, tannins, saponin, chlorophyll, nontoxic alkaloid, and anthocyanin. Meanwhile, the pharmacological analysis revealed that this plant possessed various activities such as antimicrobial, immunomodulatory, antioxidant, anti-inflammation, anti-analgetic, woundhealing, anti-hemorrhoid, anti-diabetic, and estrogenic effects. However, most of its pharmacological activities were based on the crude extracts and the bioactive compounds responsible for the bioactivities have not been well identified. A further detailed investigation in phytochemistry to identify the bioactive compounds and to investigate the mechanism action of its bioactivities is required. Moreover, a toxicology study is also needed to develop a standardized formulation of &lt;em&gt;G. pictum&lt;/em&gt; preparation and to fulfill the requirements of modern phytomedicine.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">835</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Feda Makkiyah&lt;sup&gt;1,&lt;/sup&gt;*, Eldiza Puji Rahmi&lt;sup&gt;2&lt;/sup&gt;, Rika Revina2, Tiwuk Susantiningsih&lt;sup&gt;1&lt;/sup&gt;, Yuni Setyaningsih&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Faculty of Medicine, Universitas Pembangunan Nasional Veteran Jakarta, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Pharmacy, Universitas Pembangunan Nasional Veteran Jakarta, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Eka Sunarwidhi Prasedya</style></author><author><style face="normal" font="default" size="100%">Ni Wayan Riyani Martyasari</style></author><author><style face="normal" font="default" size="100%">Candra Dwipayana Hamdin</style></author><author><style face="normal" font="default" size="100%">Masao Miyake</style></author><author><style face="normal" font="default" size="100%">Daisuke Kobayashi</style></author><author><style face="normal" font="default" size="100%">Sri Widyastuti</style></author><author><style face="normal" font="default" size="100%">Akihiro Hazama</style></author><author><style face="normal" font="default" size="100%">Haji Sunarpi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effectiveness of Methanol Solvent Extraction for Red Macroalgae Acanthophora spicifera Antitumoric Activity</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Acanthophora</style></keyword><keyword><style  face="normal" font="default" size="100%">Antiproliferative</style></keyword><keyword><style  face="normal" font="default" size="100%">Cytotoxicity</style></keyword><keyword><style  face="normal" font="default" size="100%">Indonesia</style></keyword><keyword><style  face="normal" font="default" size="100%">Macroalgae</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">May 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">450-454</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Red macroalgae &lt;em&gt;Acanthophora spicifera&lt;/em&gt; is commonly found in most parts of Indonesia coastal areas. However, information regarding their potential pharmaceutical uses remains largely unexplored. This study evaluates the antiproliferative activity of &lt;em&gt;Acanthophora spicifera&lt;/em&gt; collected from Indonesian extracted with different solvents of ethanol and methanol. &lt;strong&gt;Methods:&lt;/strong&gt; Cytotoxicity and antiproliferative activity of &lt;em&gt;A. spicifera&lt;/em&gt; crude ethanol extract (AS-EtOH) and &lt;em&gt;A. spicifera&lt;/em&gt; crude methanol extract (AM-MetOH) were evaluated with Lactate dehidrogenase (LDH) and Trypan blue exclusion assay in Human cervical cancer (HeLa) cells for 72h. Concentration of extracts treated in HeLa cells were 6.25 to 200 &lt;em&gt;μ&lt;/em&gt;g/mL. Viability staining with fluorescence stain Hoechst33342/PI was conducted to investigate apoptotic activity. Potential apoptotic activity of treatments was confirmed by DNA fragmentation assay. &lt;strong&gt;Results:&lt;/strong&gt; AS-MetOH demonstrated high cytotoxicity in HeLa cells with IC&lt;sub&gt;50&lt;/sub&gt; of 127.3 ± 33.13 &lt;em&gt;μ&lt;/em&gt;g/mL. However, AS-EtOH IC&lt;sub&gt;50&lt;/sub&gt; values could not be determined in this study. Antiproliferative activity was highly significant in AS-MetOH treated cells as cell density was suppressed to 20 x 10&lt;sup&gt;4&lt;/sup&gt; cells/mL compared to AS-EtOH (73 x 10&lt;sup&gt;4&lt;/sup&gt; cells/mL) and untreated cells (83 x 10&lt;sup&gt;4&lt;/sup&gt; cells/mL). Finally, apoptotic activity could be determined in AS-MetOH treated cells with increase PI fluorescence emitting cells and DNA fragmentation. On the other hand, apoptotic activity was not observable in AS-EtOH treated cells based on fluorescence viability staining and DNA fragmentation assay. &lt;strong&gt;Conclusion:&lt;/strong&gt; Current results show methanol solvent as an effective solvent to promote potential pharmaceutical properties of macroalgae &lt;em&gt;A. spicifera. &lt;/em&gt;Further advanced studies in a compound level from&lt;em&gt; A. spicifera&lt;/em&gt; methanol fraction would be reasonable for development of macroalgae based anticancer agent.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">450</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Eka Sunarwidhi Prasedya&lt;sup&gt;1&lt;/sup&gt;, Ni Wayan Riyani Martyasari&lt;sup&gt;2&lt;/sup&gt;, Candra Dwipayana Hamdin&lt;sup&gt;2&lt;/sup&gt;, Masao Miyake&lt;sup&gt;4&lt;/sup&gt;, Daisuke Kobayashi&lt;sup&gt;4&lt;/sup&gt;, Sri Widyastuti&lt;sup&gt;3&lt;/sup&gt;, Akihiro Hazama&lt;sup&gt;4&lt;/sup&gt;, Haji Sunarpi&lt;sup&gt;1,&lt;/sup&gt;* &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Bioscience and Biotechnology Research Centre, Faculty of Mathematics and Natural Sciences, University of Mataram, Nusa Tenggara Bar- 83126, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Pharmacy, Medical Faculty, University of Mataram, Nusa Tenggara Bar-83126 INDONSIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Faculty of Food Science and Agroindustrial Technology, University of Mataram, Nusa Tenggara Bar-83126 INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Cellular and Integrative Physiology, Fukushima Medical University, Fukushima, JAPAN.&lt;/p&gt;
</style></auth-address></record></records></xml>